CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The project aims to develop 'ImmunoChip', a device that integrates microfluidics and nanosensors to analyze the cancer-immunity cycle. This technology seeks to predict patient responses to immunotherapy, enhancing treatment strategies and potentially improving outcomes for cancer patients.
Every day cancer takes about 30000 lives worldwide, despite multiple treatments developed in the last 50 years.
True revolution in the therapy is demonstrated by the immunooncology relying on multiple routes to activate the immune system, using e.g.
Chimeric Antigen Receptors, checkpoints inhibitors.
Although demonstrating success in the treatment of e.g. lymphoma, the percentage of patients responding to the immunotherapy is less than 30%.
Even more, the activation of immune system does not hap…
HELMHOLTZ-ZENTRUM DRESDEN-ROSSENDORF EV
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
